Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT vs AC-T Regimens in Neoadjuvant Breast Cancer
NCT02613026Phase 3Completed
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Jul 2009
- Primary completion
- Mar 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of pirarubicin, docetaxel in breast cancer, sponsored by 307 Hospital of the People's Liberation Army. Started Jul 2009; status: completed.
02
Drugs
pirarubicindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02613026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02613026.